Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III adjuvant pancreatic cancer trial of 5-fluorouracil + folinic acid vs gemcitabine vs no adjuvant treatment
ISRCTN37494643Phase 3Completed
- Sponsor
- Cancer Research UK
- Start
- Jul 2000
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 3, randomised, open-label trial of fluorouracil, folinic acid and gemcitabine in pancreatic cancer (PC) (3 arms), sponsored by Cancer Research UK. Primary endpoints: Overall survival at 2 years, Overall survival at 5 years and 3 more. Started Jul 2000; status: completed.
02
Drugs
fluorouracilfolinic acidgemcitabine
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on ISRCTN37494643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN37494643.